You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

27 search results for: monitoring

expert video

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in Pediatric Patients

15 min

Type 2 Inflammation

Dr. Leonard Bacharier presents potential disease trajectories and burden for pediatric patients with type 2 inflammatory diseases.

expert video

Partnering With Patients for Clinical Decision-Making in CRSwNP

2 min

Rhinology

Profs. Wytske Fokkens and Joaquim Mullol investigate the importance of partnering with patients with CRSwNP in clinical decision-making.

expert video

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

10 min

Gastroenterology

Prof. Salvatore Oliva discusses the impact of chronic type 2 inflammation on EoE progression, highlighting the need for long-term management.

expert video

2021: EoE Year in Review

34 min

Gastroenterology

Prof. Arjan Bredenoord and Dr. Evan Dellon highlight key scientific advances made in EoE in 2021 and their potential impacts on patient care

interactivity

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

8 min

Gastroenterology

Experience a pediatric patient's journey from infancy to adolescence with guideline-based learnings on EoE diagnosis, treatment, and long-term care.

Podcast

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond

22 min

Pulmonology

Join Drs. Wanda Phipatanakul and Theresa Guilbert as they discuss the importance of routine lung function assessment in pediatric asthma patients.

interactivity

Piecing Together the Puzzle in Patients With EoE

5 min

Gastroenterology

In this hypothetical EoE patient case, learn about the different disease domains that are important in seeing the complete patient picture in EoE.

expert video

EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression

40 min

Type 2 Inflammation

Dr. Leonard Bacharier and Profs. Oscar Palomares and Stephan Weidinger explore shared features of type 2 pathophysiology in AD, asthma, and EoE, and disease burden in pediatric patients

expert video

Comorbidities and Disease Burden in CSU

10 min

Dermatology

In their interview Drs. Maurer and Ensina shed light on the significant burden of comorbidities in CSU.

expert video

ESPGHAN 2024 | Clinical Management of EoE in Adolescents to Adulthood

14 min

Gastroenterology

Prof. Salvatore Oliva discusses the latest treatment options for adolescents and adults with EoE and the importance of effective transition of care.

expert video

Guideline and Patient Management in CSU

4 min

Dermatology

Drs. Maurer and Ensina discuss cutting-edge strategies for managing CSU in this insightful interview.

expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

2 min

Pulmonology

Dr. Michael Blaiss describes the importance of lung function assessment in pediatric asthma management

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: EgyptChange country/region